Kingsview Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.21M Sell
24,623
-1,937
-7% -$637K 0.1% 213
2025
Q4
$9.31M Sell
26,560
-14,415
-35% -$4.87M 0.13% 139
2025
Q3
$13.2M Buy
40,975
+16,552
+68% +$5.15M 0.2% 95
2025
Q2
$9.5M Sell
24,423
-109
-0.4% -$43.8K 0.16% 120
2025
Q1
$10.7M Buy
24,532
+1,031
+4% +$414K 0.2% 106
2024
Q4
$8.67M Buy
23,501
+6,250
+36% +$2.62M 0.17% 131
2024
Q3
$8.97M Buy
17,251
+650
+4% +$347K 0.19% 106
2024
Q2
$9M Buy
16,601
+354
+2% +$187K 0.21% 93
2024
Q1
$8.42M Buy
16,247
+771
+5% +$383K 0.21% 109
2023
Q4
$7.3M Buy
15,476
+2,929
+23% +$1.35M 0.22% 119
2023
Q3
$5.46M Buy
12,547
+8,880
+242% +$4.03M 0.2% 120
2023
Q2
$1.63M Buy
3,667
+2,574
+235% +$1.19M 0.06% 286
2023
Q1
$503K Sell
1,093
-457
-29% -$217K 0.02% 576
2022
Q4
$795K Buy
1,550
+33
+2% +$16.8K 0.03% 393
2022
Q3
$689K Sell
1,517
-1,501
-50% -$718K 0.03% 422
2022
Q2
$1.46M Buy
3,018
+1,606
+114% +$795K 0.07% 277
2022
Q1
$694K Buy
1,412
+317
+29% +$145K 0.03% 500
2021
Q4
$508K Buy
1,095
+50
+5% +$21K 0.02% 570
2021
Q3
$390K Sell
1,045
-912
-47% -$347K 0.02% 615
2021
Q2
$751K Buy
1,957
+5
+0.3% +$1.91K 0.04% 449
2021
Q1
$691K Buy
1,952
+883
+83% +$284K 0.04% 438
2020
Q4
$343K Sell
1,069
-45
-4% -$13.8K 0.02% 525
2020
Q3
$299K Buy
1,114
+1
+0.1% +$269 0.03% 476
2020
Q2
$293K Sell
1,113
-1
-0.1% -$267 0.03% 445
2020
Q1
$253K Buy
+1,114
New +$304K 0.03% 390

Other funds holding ELV

Kingsview Wealth Management's ELV Position: Q1 2026 in Review

Kingsview Wealth Management reduced its Elevance Health (ELV) stake by 7.3% in Q1 2026, selling an estimated $637K and leaving 24,623 shares worth $7.21M. The position accounts for 0.1% of the portfolio, ranked #213.

Kingsview Wealth Management first reported a position in ELV in Q1 2020 and has held it in 25 quarters since. The position peaked at $13.2M in Q3 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Kingsview Wealth Management held 24,623 shares of Elevance Health worth $7.21M as of Q1 2026.
  • Kingsview Wealth Management sold 1,937 Elevance Health shares in Q1 2026, an estimated $637K.
  • Elevance Health made up 0.1% of Kingsview Wealth Management's portfolio in Q1 2026, its #213 holding.
  • Kingsview Wealth Management first reported a position in Elevance Health in Q1 2020 and has held it in 25 quarters since.
  • Kingsview Wealth Management's Elevance Health position peaked at $13.2M in Q3 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Kingsview Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.